Hepion Pharmaceuticals, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Hepion Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2013 to Q3 2024.
  • Hepion Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$4.87M, a 53.8% increase year-over-year.
  • Hepion Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$22.7M, a 49.2% increase year-over-year.
  • Hepion Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$48.9M, a 15.9% decline from 2022.
  • Hepion Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$42.2M, a 29% decline from 2021.
  • Hepion Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$32.7M, a 60.8% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$22.7M -$4.87M +$5.66M +53.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$28.4M -$3.93M +$10.2M +72.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-14
Q1 2024 -$38.5M -$2.85M +$10.4M +78.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-14
Q4 2023 -$48.9M -$11.1M -$4.25M -62.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 -$44.7M -$10.5M -$1.98M -23.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$42.7M -$14.1M +$5.83M +29.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-14
Q1 2023 -$48.5M -$13.3M -$6.33M -91.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-14
Q4 2022 -$42.2M -$6.81M +$2.91M +29.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 -$45.1M -$8.55M +$722K +7.79% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$45.8M -$19.9M -$12.2M -160% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-20
Q1 2022 -$33.6M -$6.93M -$866K -14.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-20
Q4 2021 -$32.7M -$9.72M -$4.77M -96.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-10
Q3 2021 -$28M -$9.27M -$3.04M -48.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$24.9M -$7.67M -$2.73M -55.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$22.2M -$6.06M -$1.84M -43.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$20.4M -$4.96M -$2.74M -124% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-08
Q3 2020 -$17.6M -$6.23M -$4.41M -242% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$13.2M -$4.94M -$3.92M -384% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$9.28M -$4.23M -$2.24M -113% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$7.04M -$2.21M +$360K +14% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$7.4M -$1.82M -$1.66M -1059% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$5.73M -$1.02M +$3.01M +74.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-16
Q1 2019 -$8.74M -$1.98M +$707K +26.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-16
Q4 2018 -$9.45M -$2.57M Oct 1, 2018 Dec 31, 2018 10-K 2020-05-14
Q3 2018 -$157K +$5.62M +97.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$4.03M -$6.08M -297% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$2.69M +$4.93M +64.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-14
Q3 2017 -$15.8M -$5.77M -$957K -19.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$14.9M $2.05M +$7.26M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$22.1M -$7.62M -$3.7M -94.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$18.4M -$4.51M -$1.48M -48.7% Oct 1, 2016 Dec 31, 2016 10-Q 2017-02-14
Q3 2016 -$17M -$4.82M +$27.5K +0.57% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$17M -$5.21M +$169K +3.14% Apr 1, 2016 Jun 30, 2016 10-KT 2018-03-26
Q1 2016 -$17.2M -$3.92M +$480K +10.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-12
Q4 2015 -$17.6M -$3.03M +$74K +2.38% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q3 2015 -$17.7M -$4.84M -$3.37M -229% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$14.3M -$5.38M Apr 1, 2015 Jun 30, 2015 10-K 2016-09-28
Q1 2015 -$4.4M +$4.91M +52.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$3.1M -$2.94M -1746% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-12
Q3 2014 -$1.47M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q1 2014 -$9.31M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$168K Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.